Smartphone apps have the potential to enhance the safety of antithrombotic therapies, highlighting a need for comprehensive tools and updated legal policies to support their development.
May support guideline app use to reduce antithrombotic adverse events; leaves open need for comprehensive tools and confirmatory trials.
Throughout the evaluated data, patients from all age groups receiving antithrombotic drugs expressed the desire for a digital tool that could support their therapy management. In addition, physicians using mobile guideline-based apps may have contributed to decreased adverse event rates among their patients. In general, digital apps encompassing both user-friendly designs and scientific backgrounds may enhance the safety of antithrombotic therapies. However, our evaluation did not identify any apps that addressed all antithrombotic drugs in combination with perioperative stratification strategies. Currently, strict regulations for smartphone apps seem to negatively affect the development of new apps. Therefore, new legal policies for medical digital apps are urgently needed.
No takes yet. Share an insight, caveat, or question.
Praus et al. (2022) studied this question.